ID   HEXB_HUMAN              Reviewed;         556 AA.
AC   P07686;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 3.
DT   10-MAY-2017, entry version 191.
DE   RecName: Full=Beta-hexosaminidase subunit beta;
DE            EC=3.2.1.52;
DE   AltName: Full=Beta-N-acetylhexosaminidase subunit beta;
DE            Short=Hexosaminidase subunit B;
DE   AltName: Full=Cervical cancer proto-oncogene 7 protein;
DE            Short=HCC-7;
DE   AltName: Full=N-acetyl-beta-glucosaminidase subunit beta;
DE   Contains:
DE     RecName: Full=Beta-hexosaminidase subunit beta chain B;
DE   Contains:
DE     RecName: Full=Beta-hexosaminidase subunit beta chain A;
DE   Flags: Precursor;
GN   Name=HEXB; ORFNames=HCC7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3013851;
RA   Korneluk R.G., Mahuran D.J., Neote K., Klavins M.H., O'Dowd B.F.,
RA   Tropak M., Willard H.F., Anderson M.-J., Lowden J.A., Gravel R.A.;
RT   "Isolation of cDNA clones coding for the alpha-subunit of human beta-
RT   hexosaminidase. Extensive homology between the alpha- and beta-
RT   subunits and studies on Tay-Sachs disease.";
RL   J. Biol. Chem. 261:8407-8413(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2977375; DOI=10.1016/0888-7543(88)90116-4;
RA   Neote K., Bapat B., Dumbrille-Ross A., Troxel C., Schuster S.M.,
RA   Mahuran D.J., Gravel R.A.;
RT   "Characterization of the human HEXB gene encoding lysosomal beta-
RT   hexosaminidase.";
RL   Genomics 3:279-286(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2964638; DOI=10.1073/pnas.85.6.1883;
RA   Proia R.L.;
RT   "Gene encoding the human beta-hexosaminidase beta chain: extensive
RT   homology of intron placement in the alpha- and beta-chain genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:1883-1887(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kim J.W.;
RT   "Identification of a new proto-oncogene in human cancers.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-67.
RX   PubMed=2971039;
RA   Sonderfeld-Fresko S., Proia R.L.;
RT   "Synthesis and assembly of a catalytically active lysosomal enzyme,
RT   beta-hexosaminidase B, in a cell-free system.";
RL   J. Biol. Chem. 263:13463-13469(1988).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-52.
RX   PubMed=2147427;
RA   Neote K., Brown C.A., Mahuran D.J., Gravel R.A.;
RT   "Translation initiation in the HEXB gene encoding the beta-subunit of
RT   human beta-hexosaminidase.";
RL   J. Biol. Chem. 265:20799-20806(1990).
RN   [10]
RP   PROTEIN SEQUENCE OF 43-57 AND 122-151.
RX   PubMed=2966076; DOI=10.1016/0014-5793(88)80699-9;
RA   Stirling J., Leung A., Gravel R.A., Mahuran D.;
RT   "Localization of the pro-sequence within the total deduced primary
RT   structure of human beta-hexosaminidase B.";
RL   FEBS Lett. 231:47-50(1988).
RN   [11]
RP   PROTEIN SEQUENCE OF 45-54 AND 315-324.
RX   PubMed=2139028;
RA   Mahuran D.J.;
RT   "Characterization of human placental beta-hexosaminidase I2.
RT   Proteolytic processing intermediates of hexosaminidase A.";
RL   J. Biol. Chem. 265:6794-6799(1990).
RN   [12]
RP   PROTEIN SEQUENCE OF 50-59.
RX   PubMed=2525487; DOI=10.1016/0014-5793(89)80649-0;
RA   Hubbes M., Callahan J., Gravel R., Mahuran D.;
RT   "The amino-terminal sequences in the pro-alpha and -beta polypeptides
RT   of human lysosomal beta-hexosaminidase A and B are retained in the
RT   mature isozymes.";
RL   FEBS Lett. 249:316-320(1989).
RN   [13]
RP   PROTEIN SEQUENCE OF 122-151 AND 315-340.
RX   PubMed=2965147;
RA   Mahuran D.J., Neote K., Klavins M.H., Leung A., Gravel R.A.;
RT   "Proteolytic processing of pro-alpha and pro-beta precursors from
RT   human beta-hexosaminidase. Generation of the mature alpha and beta a
RT   beta b subunits.";
RL   J. Biol. Chem. 263:4612-4618(1988).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 226-283.
RX   PubMed=2579389; DOI=10.1073/pnas.82.4.1184;
RA   O'Dowd B.F., Quan F., Willard H.F., Lamhonwah A.-M., Korneluk R.G.,
RA   Lowden J.A., Gravel R.A., Mahuran D.J.;
RT   "Isolation of cDNA clones coding for the beta subunit of human beta-
RT   hexosaminidase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:1184-1188(1985).
RN   [15]
RP   STRUCTURE OF CARBOHYDRATES.
RX   PubMed=2971395; DOI=10.1021/bi00414a041;
RA   O'Dowd B.F., Cumming D.A., Gravel R.A., Mahuran D.J.;
RT   "Oligosaccharide structure and amino acid sequence of the major
RT   glycopeptides of mature human beta-hexosaminidase.";
RL   Biochemistry 27:5216-5226(1988).
RN   [16]
RP   GLYCOSYLATION AT ASN-327.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [17]
RP   DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-84; ASN-142; ASN-190 AND
RP   ASN-327.
RX   PubMed=11447134; DOI=10.1093/glycob/11.7.549;
RA   Schuette C.G., Weisgerber J., Sandhoff K.;
RT   "Complete analysis of the glycosylation and disulfide bond pattern of
RT   human beta-hexosaminidase B by MALDI-MS.";
RL   Glycobiology 11:549-556(2001).
RN   [18]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-84; ASN-323 AND ASN-327.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   3D-STRUCTURE MODELING.
RX   PubMed=8673609; DOI=10.1038/nsb0796-638;
RA   Tews I., Perrakis A., Oppenheim A., Dauter Z., Wilson K.S.,
RA   Vorgias C.E.;
RT   "Bacterial chitobiase structure provides insight into catalytic
RT   mechanism and the basis of Tay-Sachs disease.";
RL   Nat. Struct. Biol. 3:638-648(1996).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 50-556, AND DISULFIDE BONDS.
RX   PubMed=12662933; DOI=10.1016/S0022-2836(03)00216-X;
RA   Mark B.L., Mahuran D.J., Cherney M.M., Zhao D., Knapp S., James M.N.;
RT   "Crystal structure of human beta-hexosaminidase B: understanding the
RT   molecular basis of Sandhoff and Tay-Sachs disease.";
RL   J. Mol. Biol. 327:1093-1109(2003).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 42-556, AND DISULFIDE BONDS.
RX   PubMed=12706724; DOI=10.1016/S0022-2836(03)00311-5;
RA   Maier T., Strater N., Schuette C.G., Klingenstein R., Sandhoff K.,
RA   Saenger W.;
RT   "The X-ray crystal structure of human beta-hexosaminidase B provides
RT   new insights into Sandhoff disease.";
RL   J. Mol. Biol. 328:669-681(2003).
RN   [25]
RP   REVIEW ON VARIANTS.
RX   PubMed=1825792; DOI=10.1016/0925-4439(91)90044-A;
RA   Mahuran D.J.;
RT   "The biochemistry of HEXA and HEXB gene mutations causing GM2
RT   gangliosidosis.";
RL   Biochim. Biophys. Acta 1096:87-94(1991).
RN   [26]
RP   VARIANT GM2G2 SER-456, AND VARIANT VAL-207.
RX   PubMed=1720305; DOI=10.1016/S0006-291X(05)81388-9;
RA   Banerjee P., Siciliano L., Oliveri D., McCabe N.R., Boyers M.J.,
RA   Horwitz A.L., Li S.-C., Dawson G.;
RT   "Molecular basis of an adult form of beta-hexosaminidase B deficiency
RT   with motor neuron disease.";
RL   Biochem. Biophys. Res. Commun. 181:108-115(1991).
RN   [27]
RP   VARIANT GM2G2 LEU-417.
RX   PubMed=1531140;
RA   Wakamatsu N., Kobayashi H., Miyatake T., Tsuji S.;
RT   "A novel exon mutation in the human beta-hexosaminidase beta subunit
RT   gene affects 3' splice site selection.";
RL   J. Biol. Chem. 267:2406-2413(1992).
RN   [28]
RP   VARIANT GM2G2 GLN-505.
RX   PubMed=8357844; DOI=10.1016/0925-4439(93)90134-M;
RA   Bolhuis P.A., Ponne N.J., Bikker H., Baas F., Vianney de Jong J.M.B.;
RT   "Molecular basis of an adult form of Sandhoff disease: substitution of
RT   glutamine for arginine at position 505 of the beta-chain of beta-
RT   hexosaminidase results in a labile enzyme.";
RL   Biochim. Biophys. Acta 1182:142-146(1993).
RN   [29]
RP   VARIANT GM2G2 TYR-534.
RX   PubMed=7626071; DOI=10.1006/bbrc.1995.2007;
RA   Kuroki Y., Itoh K., Nadaoka Y., Tanaka T., Sakuraba H.;
RT   "A novel missense mutation (C522Y) is present in the beta-
RT   hexosaminidase beta-subunit gene of a Japanese patient with infantile
RT   Sandhoff disease.";
RL   Biochem. Biophys. Res. Commun. 212:564-571(1995).
RN   [30]
RP   VARIANTS GM2G2 TYR-309 AND LEU-417.
RX   PubMed=7557963; DOI=10.1007/BF00191799;
RA   Gomez-Lira M., Sangalli A., Mottes M., Perusi C., Pignatti P.F.,
RA   Rizzuto N., Salviati A.;
RT   "A common beta hexosaminidase gene mutation in adult Sandhoff disease
RT   patients.";
RL   Hum. Genet. 96:417-422(1995).
RN   [31]
RP   VARIANT GM2G2 LEU-62.
RX   PubMed=7633435; DOI=10.1093/hmg/4.4.777;
RA   Zhang Z.-X., Wakamatsu N., Akerman B.R., Mules E.H., Thomas G.H.,
RA   Gravel R.A.;
RT   "A second, large deletion in the HEXB gene in a patient with infantile
RT   Sandhoff disease.";
RL   Hum. Mol. Genet. 4:777-780(1995).
RN   [32]
RP   VARIANT GM2G2 GLN-505, AND VARIANT VAL-207.
RX   PubMed=8950198; DOI=10.1016/S0925-4439(96)00044-0;
RA   Redonnet-Vernhet I., Mahuran D.J., Salvayre R., Dubas F., Levade T.;
RT   "Significance of two point mutations present in each HEXB allele of
RT   patients with adult GM2 gangliosidosis (Sandhoff disease) homozygosity
RT   for the Ile207-->Val substitution is not associated with a clinical or
RT   biochemical phenotype.";
RL   Biochim. Biophys. Acta 1317:127-133(1996).
RN   [33]
RP   VARIANT GM2G2 THR-543.
RX   PubMed=9401004;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:6<424::AID-HUMU2>3.3.CO;2-Y;
RA   Narkis G., Adam A., Jaber L., Pennybacker M., Proia R.L., Navon R.;
RT   "Molecular basis of heat labile hexosaminidase B among Jews and
RT   Arabs.";
RL   Hum. Mutat. 10:424-429(1997).
RN   [34]
RP   VARIANT GM2G2 ARG-255.
RX   PubMed=9856491; DOI=10.1007/s004390050851;
RA   Fujimaru M., Tanaka A., Choeh K., Wakamatsu N., Sakuraba H.,
RA   Isshiki G.;
RT   "Two mutations remote from an exon/intron junction in the beta-
RT   hexosaminidase beta-subunit gene affect 3'-splice site selection and
RT   cause Sandhoff disease.";
RL   Hum. Genet. 103:462-469(1998).
RN   [35]
RP   VARIANT GM2G2 SER-504.
RX   PubMed=9694901; DOI=10.1074/jbc.273.33.21386;
RA   Hou Y., McInnes B., Hinek A., Karpati G., Mahuran D.;
RT   "A Pro504 --> Ser substitution in the beta-subunit of beta-
RT   hexosaminidase A inhibits alpha-subunit hydrolysis of GM2 ganglioside,
RT   resulting in chronic Sandhoff disease.";
RL   J. Biol. Chem. 273:21386-21392(1998).
CC   -!- FUNCTION: Responsible for the degradation of GM2 gangliosides, and
CC       a variety of other molecules containing terminal N-acetyl
CC       hexosamines, in the brain and other tissues.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of terminal non-reducing N-acetyl-
CC       D-hexosamine residues in N-acetyl-beta-D-hexosaminides.
CC   -!- SUBUNIT: There are 3 forms of beta-hexosaminidase: hexosaminidase
CC       A is a trimer composed of one subunit alpha, one subunit beta
CC       chain A and one subunit beta chain B; hexosaminidase B is a
CC       tetramer of two subunit beta chains A and two subunit beta chains
CC       B; hexosaminidase S is a homodimer of two alpha subunits. The two
CC       beta chains are derived from the cleavage of the beta subunit.
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- PTM: N-linked glycans at Asn-142 and Asn-190 consist of Man(3)-
CC       GlcNAc(2) and Man(5 to 7)-GlcNAc(2), respectively.
CC       {ECO:0000269|PubMed:11447134, ECO:0000269|PubMed:12754519,
CC       ECO:0000269|PubMed:19159218}.
CC   -!- PTM: The beta-A and beta-B chains are produced by proteolytic
CC       processing of the precursor beta chain.
CC   -!- DISEASE: GM2-gangliosidosis 2 (GM2G2) [MIM:268800]: An autosomal
CC       recessive lysosomal storage disease marked by the accumulation of
CC       GM2 gangliosides in the neuronal cells. Clinically
CC       indistinguishable from GM2-gangliosidosis type 1, presenting
CC       startle reactions, early blindness, progressive motor and mental
CC       deterioration, macrocephaly and cherry-red spots on the macula.
CC       {ECO:0000269|PubMed:1531140, ECO:0000269|PubMed:1720305,
CC       ECO:0000269|PubMed:7557963, ECO:0000269|PubMed:7626071,
CC       ECO:0000269|PubMed:7633435, ECO:0000269|PubMed:8357844,
CC       ECO:0000269|PubMed:8950198, ECO:0000269|PubMed:9401004,
CC       ECO:0000269|PubMed:9694901, ECO:0000269|PubMed:9856491}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 20 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA51828.1; Type=Frameshift; Positions=21; Evidence={ECO:0000305};
CC       Sequence=AAA68620.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=HEXBdb; Note=HEXB mutation database;
CC       URL="http://www.hexdb.mcgill.ca/?Topic=HEXBdb";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M13519; AAA51828.1; ALT_FRAME; mRNA.
DR   EMBL; M23294; AAA52645.1; -; Genomic_DNA.
DR   EMBL; M23282; AAA52645.1; JOINED; Genomic_DNA.
DR   EMBL; M23283; AAA52645.1; JOINED; Genomic_DNA.
DR   EMBL; M23284; AAA52645.1; JOINED; Genomic_DNA.
DR   EMBL; M23285; AAA52645.1; JOINED; Genomic_DNA.
DR   EMBL; M23286; AAA52645.1; JOINED; Genomic_DNA.
DR   EMBL; M23287; AAA52645.1; JOINED; Genomic_DNA.
DR   EMBL; M23288; AAA52645.1; JOINED; Genomic_DNA.
DR   EMBL; M23290; AAA52645.1; JOINED; Genomic_DNA.
DR   EMBL; M23291; AAA52645.1; JOINED; Genomic_DNA.
DR   EMBL; M23292; AAA52645.1; JOINED; Genomic_DNA.
DR   EMBL; M23293; AAA52645.1; JOINED; Genomic_DNA.
DR   EMBL; M19735; AAA68620.1; ALT_INIT; mRNA.
DR   EMBL; AF378118; AAM46114.1; -; mRNA.
DR   EMBL; BT009919; AAP88921.1; -; mRNA.
DR   EMBL; AC026405; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093214; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC017378; AAH17378.1; -; mRNA.
DR   EMBL; M34906; AAA51829.1; -; mRNA.
DR   CCDS; CCDS4022.1; -.
DR   PIR; A31250; A31250.
DR   RefSeq; NP_000512.1; NM_000521.3.
DR   RefSeq; NP_001278933.1; NM_001292004.1.
DR   UniGene; Hs.69293; -.
DR   PDB; 1NOU; X-ray; 2.40 A; A/B=50-556.
DR   PDB; 1NOW; X-ray; 2.20 A; A/B=50-556.
DR   PDB; 1NP0; X-ray; 2.50 A; A/B=50-556.
DR   PDB; 1O7A; X-ray; 2.25 A; A/B/C/D/E/F=42-556.
DR   PDB; 1QBD; Model; -; A=122-556.
DR   PDB; 2GJX; X-ray; 2.80 A; B/C/F/G=50-556.
DR   PDB; 2GK1; X-ray; 3.25 A; B/D/F/H=50-552.
DR   PDB; 3LMY; X-ray; 2.80 A; A/B=1-556.
DR   PDB; 5BRO; X-ray; 2.40 A; A=43-556.
DR   PDBsum; 1NOU; -.
DR   PDBsum; 1NOW; -.
DR   PDBsum; 1NP0; -.
DR   PDBsum; 1O7A; -.
DR   PDBsum; 1QBD; -.
DR   PDBsum; 2GJX; -.
DR   PDBsum; 2GK1; -.
DR   PDBsum; 3LMY; -.
DR   PDBsum; 5BRO; -.
DR   ProteinModelPortal; P07686; -.
DR   SMR; P07686; -.
DR   BioGrid; 109323; 32.
DR   IntAct; P07686; 10.
DR   MINT; MINT-4528380; -.
DR   STRING; 9606.ENSP00000261416; -.
DR   BindingDB; P07686; -.
DR   ChEMBL; CHEMBL5877; -.
DR   CAZy; GH20; Glycoside Hydrolase Family 20.
DR   iPTMnet; P07686; -.
DR   PhosphoSitePlus; P07686; -.
DR   SwissPalm; P07686; -.
DR   UniCarbKB; P07686; -.
DR   BioMuta; HEXB; -.
DR   DMDM; 123081; -.
DR   UCD-2DPAGE; P07686; -.
DR   EPD; P07686; -.
DR   MaxQB; P07686; -.
DR   PaxDb; P07686; -.
DR   PeptideAtlas; P07686; -.
DR   PRIDE; P07686; -.
DR   TopDownProteomics; P07686; -.
DR   DNASU; 3074; -.
DR   Ensembl; ENST00000261416; ENSP00000261416; ENSG00000049860.
DR   GeneID; 3074; -.
DR   KEGG; hsa:3074; -.
DR   UCSC; uc003kdf.4; human.
DR   CTD; 3074; -.
DR   DisGeNET; 3074; -.
DR   GeneCards; HEXB; -.
DR   HGNC; HGNC:4879; HEXB.
DR   HPA; HPA055409; -.
DR   HPA; HPA056010; -.
DR   MalaCards; HEXB; -.
DR   MIM; 268800; phenotype.
DR   MIM; 606873; gene.
DR   neXtProt; NX_P07686; -.
DR   Orphanet; 309169; Sandhoff disease, adult form.
DR   Orphanet; 309155; Sandhoff disease, infantile form.
DR   Orphanet; 309162; Sandhoff disease, juvenile form.
DR   PharmGKB; PA29257; -.
DR   eggNOG; KOG2499; Eukaryota.
DR   eggNOG; COG3525; LUCA.
DR   HOGENOM; HOG000157972; -.
DR   HOVERGEN; HBG005961; -.
DR   InParanoid; P07686; -.
DR   KO; K12373; -.
DR   OrthoDB; EOG091G04NA; -.
DR   PhylomeDB; P07686; -.
DR   TreeFam; TF313036; -.
DR   BioCyc; MetaCyc:HS00629-MONOMER; -.
DR   BRENDA; 3.2.1.52; 2681.
DR   Reactome; R-HSA-1660662; Glycosphingolipid metabolism.
DR   Reactome; R-HSA-2022857; Keratan sulfate degradation.
DR   Reactome; R-HSA-2024101; CS/DS degradation.
DR   Reactome; R-HSA-2160916; Hyaluronan uptake and degradation.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SABIO-RK; P07686; -.
DR   ChiTaRS; HEXB; human.
DR   EvolutionaryTrace; P07686; -.
DR   GeneWiki; HEXB; -.
DR   GenomeRNAi; 3074; -.
DR   PRO; PR:P07686; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000049860; -.
DR   CleanEx; HS_HEXB; -.
DR   ExpressionAtlas; P07686; baseline and differential.
DR   Genevisible; P07686; HS.
DR   GO; GO:0001669; C:acrosomal vesicle; IEA:Ensembl.
DR   GO; GO:0042582; C:azurophil granule; IDA:UniProtKB.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0008375; F:acetylglucosaminyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0004563; F:beta-N-acetylhexosaminidase activity; TAS:Reactome.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:MGI.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:MGI.
DR   GO; GO:0043615; P:astrocyte cell migration; IEA:Ensembl.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IEA:Ensembl.
DR   GO; GO:0044267; P:cellular protein metabolic process; IEA:Ensembl.
DR   GO; GO:0030207; P:chondroitin sulfate catabolic process; TAS:Reactome.
DR   GO; GO:0006689; P:ganglioside catabolic process; IEA:Ensembl.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome.
DR   GO; GO:0030214; P:hyaluronan catabolic process; TAS:Reactome.
DR   GO; GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome.
DR   GO; GO:0019915; P:lipid storage; IEA:Ensembl.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0007040; P:lysosome organization; IEA:Ensembl.
DR   GO; GO:0008049; P:male courtship behavior; IEA:Ensembl.
DR   GO; GO:0042552; P:myelination; IEA:Ensembl.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0009313; P:oligosaccharide catabolic process; IEA:Ensembl.
DR   GO; GO:0048477; P:oogenesis; IEA:Ensembl.
DR   GO; GO:0007341; P:penetration of zona pellucida; IEA:Ensembl.
DR   GO; GO:0008654; P:phospholipid biosynthetic process; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:Ensembl.
DR   GO; GO:0007605; P:sensory perception of sound; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; IEA:Ensembl.
DR   InterPro; IPR025705; Beta_hexosaminidase_sua/sub.
DR   InterPro; IPR029018; Chitobiase/Hex_dom_2-like.
DR   InterPro; IPR015883; Glyco_hydro_20_cat.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   InterPro; IPR029019; HEX_eukaryotic_N.
DR   Pfam; PF00728; Glyco_hydro_20; 1.
DR   Pfam; PF14845; Glycohydro_20b2; 1.
DR   PIRSF; PIRSF001093; B-hxosamndse_ab_euk_; 1.
DR   PRINTS; PR00738; GLHYDRLASE20.
DR   SUPFAM; SSF51445; SSF51445; 1.
DR   SUPFAM; SSF55545; SSF55545; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Disease mutation; Disulfide bond; Gangliosidosis; Glycoprotein;
KW   Glycosidase; Hydrolase; Lysosome; Neurodegeneration; Polymorphism;
KW   Reference proteome; Signal; Zymogen.
FT   SIGNAL        1     42       {ECO:0000255}.
FT   PROPEP       43    121       {ECO:0000269|PubMed:2965147,
FT                                ECO:0000269|PubMed:2966076}.
FT                                /FTId=PRO_0000012002.
FT   CHAIN       122    556       Beta-hexosaminidase subunit beta.
FT                                /FTId=PRO_0000012003.
FT   CHAIN       122    311       Beta-hexosaminidase subunit beta chain B.
FT                                /FTId=PRO_0000012004.
FT   CHAIN       315    556       Beta-hexosaminidase subunit beta chain A.
FT                                /FTId=PRO_0000012005.
FT   ACT_SITE    355    355       Proton donor. {ECO:0000250}.
FT   SITE        497    497       Not glycosylated.
FT                                {ECO:0000269|PubMed:11447134}.
FT   CARBOHYD     84     84       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:11447134,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    142    142       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:11447134}.
FT   CARBOHYD    190    190       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:11447134}.
FT   CARBOHYD    323    323       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    327    327       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:11447134,
FT                                ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:19159218}.
FT   DISULFID     91    137
FT   DISULFID    309    360
FT   DISULFID    534    551
FT   VARIANT      62     62       S -> L (in GM2G2; dbSNP:rs820878).
FT                                {ECO:0000269|PubMed:7633435}.
FT                                /FTId=VAR_003247.
FT   VARIANT     121    121       K -> R (in dbSNP:rs11556045).
FT                                /FTId=VAR_003248.
FT   VARIANT     207    207       I -> V (probable polymorphism;
FT                                dbSNP:rs10805890).
FT                                {ECO:0000269|PubMed:1720305,
FT                                ECO:0000269|PubMed:8950198}.
FT                                /FTId=VAR_003249.
FT   VARIANT     255    255       S -> R (in GM2G2).
FT                                {ECO:0000269|PubMed:9856491}.
FT                                /FTId=VAR_011704.
FT   VARIANT     309    309       C -> Y (in GM2G2; adult type; severe).
FT                                {ECO:0000269|PubMed:7557963}.
FT                                /FTId=VAR_003250.
FT   VARIANT     417    417       P -> L (in GM2G2; dbSNP:rs28942073).
FT                                {ECO:0000269|PubMed:1531140,
FT                                ECO:0000269|PubMed:7557963}.
FT                                /FTId=VAR_003251.
FT   VARIANT     456    456       Y -> S (in GM2G2).
FT                                {ECO:0000269|PubMed:1720305}.
FT                                /FTId=VAR_003252.
FT   VARIANT     504    504       P -> S (in GM2G2).
FT                                {ECO:0000269|PubMed:9694901}.
FT                                /FTId=VAR_011705.
FT   VARIANT     505    505       R -> Q (in GM2G2).
FT                                {ECO:0000269|PubMed:8357844,
FT                                ECO:0000269|PubMed:8950198}.
FT                                /FTId=VAR_003253.
FT   VARIANT     534    534       C -> Y (in GM2G2; infantile type).
FT                                {ECO:0000269|PubMed:7626071}.
FT                                /FTId=VAR_003254.
FT   VARIANT     543    543       A -> T (in GM2G2).
FT                                {ECO:0000269|PubMed:9401004}.
FT                                /FTId=VAR_011706.
FT   STRAND       61     71       {ECO:0000244|PDB:1NOW}.
FT   HELIX        74     76       {ECO:0000244|PDB:1NOW}.
FT   STRAND       78     81       {ECO:0000244|PDB:1NOW}.
FT   STRAND       83     86       {ECO:0000244|PDB:1O7A}.
FT   HELIX        92    105       {ECO:0000244|PDB:1NOW}.
FT   STRAND      126    131       {ECO:0000244|PDB:1NOW}.
FT   STRAND      149    153       {ECO:0000244|PDB:1NOW}.
FT   STRAND      155    164       {ECO:0000244|PDB:1NOW}.
FT   HELIX       165    178       {ECO:0000244|PDB:1NOW}.
FT   STRAND      187    196       {ECO:0000244|PDB:1NOW}.
FT   STRAND      201    212       {ECO:0000244|PDB:1NOW}.
FT   HELIX       216    228       {ECO:0000244|PDB:1NOW}.
FT   STRAND      233    237       {ECO:0000244|PDB:1NOW}.
FT   HELIX       253    258       {ECO:0000244|PDB:1NOW}.
FT   STRAND      259    261       {ECO:0000244|PDB:1NOW}.
FT   STRAND      262    264       {ECO:0000244|PDB:2GJX}.
FT   HELIX       268    280       {ECO:0000244|PDB:1NOW}.
FT   STRAND      284    294       {ECO:0000244|PDB:1NOW}.
FT   HELIX       298    301       {ECO:0000244|PDB:1NOW}.
FT   STRAND      306    308       {ECO:0000244|PDB:1NOW}.
FT   STRAND      318    322       {ECO:0000244|PDB:1NOW}.
FT   HELIX       327    343       {ECO:0000244|PDB:1NOW}.
FT   STRAND      346    352       {ECO:0000244|PDB:1NOW}.
FT   HELIX       359    362       {ECO:0000244|PDB:1NOW}.
FT   HELIX       365    373       {ECO:0000244|PDB:1NOW}.
FT   HELIX       380    397       {ECO:0000244|PDB:1NOW}.
FT   STRAND      401    405       {ECO:0000244|PDB:1NOW}.
FT   HELIX       406    410       {ECO:0000244|PDB:1NOW}.
FT   STRAND      420    423       {ECO:0000244|PDB:1NOW}.
FT   HELIX       429    438       {ECO:0000244|PDB:1NOW}.
FT   STRAND      443    445       {ECO:0000244|PDB:1NOW}.
FT   HELIX       447    449       {ECO:0000244|PDB:3LMY}.
FT   STRAND      450    453       {ECO:0000244|PDB:2GK1}.
FT   STRAND      455    457       {ECO:0000244|PDB:2GJX}.
FT   HELIX       460    465       {ECO:0000244|PDB:1NOW}.
FT   HELIX       475    479       {ECO:0000244|PDB:1NOW}.
FT   STRAND      481    488       {ECO:0000244|PDB:1NOW}.
FT   HELIX       490    492       {ECO:0000244|PDB:3LMY}.
FT   TURN        495    497       {ECO:0000244|PDB:1NOW}.
FT   HELIX       498    502       {ECO:0000244|PDB:1NOW}.
FT   HELIX       505    514       {ECO:0000244|PDB:1NOW}.
FT   HELIX       522    538       {ECO:0000244|PDB:1NOW}.
FT   STRAND      546    548       {ECO:0000244|PDB:1NOW}.
SQ   SEQUENCE   556 AA;  63111 MW;  B3A0A36594F62536 CRC64;
     MELCGLGLPR PPMLLALLLA TLLAAMLALL TQVALVVQVA EAARAPSVSA KPGPALWPLP
     LSVKMTPNLL HLAPENFYIS HSPNSTAGPS CTLLEEAFRR YHGYIFGFYK WHHEPAEFQA
     KTQVQQLLVS ITLQSECDAF PNISSDESYT LLVKEPVAVL KANRVWGALR GLETFSQLVY
     QDSYGTFTIN ESTIIDSPRF SHRGILIDTS RHYLPVKIIL KTLDAMAFNK FNVLHWHIVD
     DQSFPYQSIT FPELSNKGSY SLSHVYTPND VRMVIEYARL RGIRVLPEFD TPGHTLSWGK
     GQKDLLTPCY SRQNKLDSFG PINPTLNTTY SFLTTFFKEI SEVFPDQFIH LGGDEVEFKC
     WESNPKIQDF MRQKGFGTDF KKLESFYIQK VLDIIATINK GSIVWQEVFD DKAKLAPGTI
     VEVWKDSAYP EELSRVTASG FPVILSAPWY LDLISYGQDW RKYYKVEPLD FGGTQKQKQL
     FIGGEACLWG EYVDATNLTP RLWPRASAVG ERLWSSKDVR DMDDAYDRLT RHRCRMVERG
     IAAQPLYAGY CNHENM
//
